Fig. 1From: Targeting autophagy increases the efficacy of proteasome inhibitor treatment in multiple myeloma by induction of apoptosis and activation of JNKIRE1α inhibitors in combination with ixazomib have synergistic effects on cytotoxicity of multiple myeloma cells under support of mesenchymal stromal cell line (hMSC-TERT). A KMS11 and RPMI-8226 cells were treated with 10 nM ixazomib alone or combined with 30 μM STF-083010 for five days with or without support of immortalized stromal cells (hMSC-TERT), (n = 3). Cell viability were measured by PI staining. B Total RNA was extracted after 16 h of treatment as described above. B, C XBP1s, ATF6 and EIF2AK3 mRNA levels were assessed using RT-qPCR, (n = 3). P values were calculated by two-way analysis of variance (ANOVA) for A, B and one-way analysis for C. A P value of less than 0.05 was considered statistically significant for all analyses. (*p < 0.05, **p < 0.01, ***p < 0.001 versus control)Back to article page